Bruce L.A. Carter's most recent trade in Enanta Pharmaceuticals Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 10,800 | 10,800 | - | - | Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 10,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. | 12 Aug 2022 | 10,000 | 16,021 (0%) | 0% | 27 | 270,000 | Common Stock |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 85.04 per share. | 12 Aug 2022 | 5,107 | 10,914 (0%) | 0% | 85.0 | 434,287 | Common Stock |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 85.96 per share. | 12 Aug 2022 | 4,893 | 6,021 (0%) | 0% | 86.0 | 420,612 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.58 per share. | 21 Mar 2022 | 6,000 | 6,000 (0%) | 0% | 25.6 | 153,480 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 66.70 per share. | 21 Mar 2022 | 2,676 | 3,324 (0%) | 0% | 66.7 | 178,489 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 68.66 per share. | 21 Mar 2022 | 2,210 | 807 (0%) | 0% | 68.7 | 151,739 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 69.52 per share. | 21 Mar 2022 | 807 | 0 (0%) | 0% | 69.5 | 56,103 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 67.23 per share. | 21 Mar 2022 | 307 | 3,017 (0%) | 0% | 67.2 | 20,640 | Common Stock |
| Enanta Pharma Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock |